Pfizer Inc. (PFE)

Precedente Chiudi:

$27.70

Aprire:

$27.86

Volume 24 ore:

45.28M

Capitalizzazione di mercato:

$157.48B

Reddito:

$55.09B

Utile/perdita netta:

$-309.00M

Rapporto P/E:

15.20

EPS:

1.83

Flusso di cassa netto:

$4.79B

1 W Prestazione:

+9.49%

1M Prestazione:

+2.17%

6M Prestazione:

-11.04%

1 anno Prestazione:

-27.67%

Intervallo 1D:

$27.52

$27.91

Portata 52W:

$25.20

$40.37

Pfizer Inc. Stock (PFE) Company Profile

Nome

Pfizer Inc.

Settore

Healthcare (1213)

Industria

Drug Manufacturers - General (18)

Telefono

212-733-2323

Indirizzo

235 East 42nd Street, New York, NY

Dipendente

90,200

Cinguettio

@Pfizer

Prossima data di guadagno

2024-05-01

Ultimi documenti SEC

PFE's Discussions on Twitter

Pfizer Inc. Stock (PFE) Upgrades & Downgrades

Data	Azione	Analista	Modifica della valutazione
2024-01-04	Downgrade	TD Cowen	Outperform → Market Perform
2023-10-20	Ripresa	UBS	Neutral
2023-10-16	Aggiornamento	Jefferies	Hold → Buy
2023-07-17	Reiterato	JP Morgan	Neutral
2023-07-14	Iniziato	HSBC Securities	Buy
2023-06-29	Downgrade	Credit Suisse	Outperform → Neutral
2023-05-11	Downgrade	Daiwa Securities	Outperform → Neutral
2023-03-06	Iniziato	Jefferies	Hold
2023-02-07	Aggiornamento	Daiwa Securities	Neutral → Outperform
2023-01-26	Downgrade	UBS	Buy → Neutral
2023-01-17	Downgrade	Wells Fargo	Overweight → Equal Weight
2023-01-04	Downgrade	BofA Securities	Buy → Neutral
2022-12-13	Aggiornamento	Goldman	Neutral → Buy
2022-11-18	Iniziato	Credit Suisse	Outperform
2022-05-23	Iniziato	SVB Leerink	Mkt Perform
2022-04-06	Ripresa	Morgan Stanley	Equal-Weight
2022-01-05	Aggiornamento	BofA Securities	Neutral → Buy
2022-01-03	Reiterato	Bernstein	Mkt Perform
2021-12-20	Reiterato	Cowen	Outperform
2021-12-17	Iniziato	Goldman	Neutral
2021-12-13	Aggiornamento	UBS	Neutral → Buy
2021-12-09	Iniziato	Wells Fargo	Overweight
2021-11-19	Iniziato	BMO Capital Markets	Outperform
2021-07-27	Ripresa	Truist	Buy
2021-05-06	Downgrade	Mizuho	Buy → Neutral
2021-04-07	Ripresa	RBC Capital Mkts	Sector Perform
2021-02-04	Aggiornamento	DZ Bank	Hold → Buy
2020-12-16	Downgrade	RBC Capital Mkts	Outperform → Sector Perform
2020-11-19	Ripresa	Goldman	Neutral
2020-11-10	Ripresa	Bernstein	Mkt Perform
2020-10-12	Downgrade	Atlantic Equities	Overweight → Neutral
2020-09-29	Iniziato	Berenberg	Hold
2020-06-16	Iniziato	SVB Leerink	Mkt Perform
2020-02-27	Iniziato	Barclays	Equal Weight
2020-02-27	Aggiornamento	Standpoint Research	Hold → Buy
2020-02-06	Iniziato	Mizuho	Buy
2020-01-07	Iniziato	RBC Capital Mkts	Outperform
2019-10-17	Ripresa	BofA/Merrill	Neutral
2019-07-30	Downgrade	BofA/Merrill	Buy → Neutral
2019-07-30	Downgrade	Morgan Stanley	Overweight → Equal-Weight
2019-06-04	Ripresa	Morgan Stanley	Overweight
2019-02-20	Ripresa	Citigroup	Neutral
2019-01-31	Aggiornamento	Argus	Hold → Buy
2019-01-31	Aggiornamento	Credit Suisse	Neutral → Outperform
2019-01-23	Downgrade	UBS	Buy → Neutral
2018-12-11	Downgrade	JP Morgan	Overweight → Neutral
2018-11-01	Downgrade	BMO Capital Markets	Outperform → Market Perform

Mostra tutto

Pfizer Inc. Borsa (PFE) Ultime notizie

Can Pfizer Challenge Lilly and Novo Nordisk in the Obesity Market?

The Motley Fool

3 High-Yield Dividend Stocks to Buy Now and Hold at Least a Decade

The Motley Fool

SCHD: A Must-Have In Every Dividend Portfolio

Seeking Alpha

Pharma Stock Roundup: LLY, NVO, PFE Q1 Results, JNJ's New Plan to Resolve Talc Claims

Zacks Investment Research

Here's Why Pfizer (PFE) is a Strong Momentum Stock

Zacks Investment Research

Pfizer Prospects Garner Mixed Sentiment From Analysts: 'Finally, The Pivot Investors Have Been Waiting For'

Benzinga

Pfizer Inc. Azioni (PFE) Dati Finanziari

Pfizer Inc. (PFE) Reddito 2024

Pfizer Inc. (PFE) Reddito netto 2024

Pfizer Inc. (PFE) Flusso di cassa 2024

Pfizer Inc. (PFE) Utile per azione 2024